SCHEDULE: Capital International Investors Updates agilon health Stake
Beneficial Ownership Statement
Capital International Investors has filed an amended Schedule 13G, reporting a 2.4% beneficial ownership stake in agilon health, Inc. as of June 30, 2025.
Summary
- Capital International Investors (CII) filed an Amendment No. 1 to Schedule 13G regarding its beneficial ownership in agilon health, Inc.
- CII beneficially owns 9,892,742 shares of agilon health, Inc. Common Stock.
- This ownership represents 2.4% of the 413,951,779 shares of Common Stock believed to be outstanding.
- CII holds sole voting power and sole dispositive power over all 9,892,742 shares.
- The event date requiring this filing was June 30, 2025, and the filing date was August 12, 2025.
Sentiment
Score: 5
Explanation: The filing is a routine disclosure of beneficial ownership by an institutional investor and does not contain information that would significantly alter the company's perceived value or outlook.
Positives
- A significant institutional investor, Capital International Investors, maintains a beneficial ownership stake in agilon health, Inc.
Future Outlook
NA
Industry Context
NA
Key Dates
| Date | Description |
|---|---|
| 06/30/2025 | Date of event which requires filing of this statement |
| 08/12/2025 | Date of filing |
Keywords
agilon health, Capital International Investors, beneficial ownership, Schedule 13G, common stock, institutional investment, healthcare
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.